StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.1
  1. Startseite
  2. /Verbindung

Icosapent

HCID 446284
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
10417-94-4
Standard-SMILES
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O
InChIKey
JAZBEHYOTPTENJ-JLNKQSITSA-N
Summenformel
C20H30O2
Durchschnittliche Molmasse
302,5 g/mol
Monoisotopische Masse
302,2245802

Überblick

All-cis-5,8,11,14,17-icosapentaenoic acid is an icosapentaenoic acid having five cis-double bonds at positions 5, 8, 11, 14 and 17. It has a role as a micronutrient, an antidepressant, an antineoplastic agent, an anticholesteremic drug, a nutraceutical, a mouse metabolite, a fungal metabolite and a Daphnia galeata metabolite. It is an omega-3 fatty acid and an icosapentaenoic acid. It is a conjugate acid of an all-cis-5,8,11,14,17-icosapentaenoate.

Namen und Bezeichner

Bevorzugter Name
Icosapent
IUPAC
(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid
Englischer Name
EPA
Summenformel
C20H30O2
Molmasse
302.45

Namen und Synonyme

IcosapentEPAIcosapentoIcosapentumMiraxionEye QEye-QRopufa 70Incromega e 7010srCCRIS 3279AAN7QOV9EAUNII-AAN7QOV9EA
Weitere Namen anzeigen
EICOSAPENTAENOIC ACIDCIS-5,8,11,14,17-EICOSAPENTAENOIC ACIDEicosapentaenoicTIMNODONIC ACIDEPA (Eicosapentaenoic Acid)Eicosapentaenoic acid (EPA)5C,8C,11C,14C,17C-EICOSAPENTAENOIC ACID5,8,11,14,17-EICOSAPENTAENOIC ACIDALL CIS-5,8,11,14,17-EICOSAPENTAENOIC ACID
Icosapento [INN-Spanish]EPA 45GEPA [drug]C20:5 (n-3)(5Z,8Z,11Z,14Z,17Z)-EicosapentaenoateIcosapentum [INN-Latin]CHEBI:28364C20:5n-3,6,9,12,15

Datenbank-Bezeichner

CAS
10417-94-4
PubChem CID
446284
DTXSID

Eigenschaften

Berechnete Struktureigenschaften

XLogP
5,6
Polarare Oberfläche (TPSA)
37,3 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
13
Schwere Atome
22
Formalladung
0
Komplexität
398

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals -> Listed in ZINC15
Lipids · 2 Einträge

Lipids -> Unambiguous Lipids

Fatty Acyls [FA] -> Fatty Acids and Conjugates [FA01] -> Unsaturated fatty acids [FA0103]

CosmeticsEmollient; Skin conditioning
SpringerMaterials PropertiesChemical diffusion
Endocrine DisruptorsPotential endocrine disrupting compound
Physical DescriptionLiquid
Collision Cross Section · 2 Einträge

180.9 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Sample Type: Human bronchoalveolar lavage fluid (BALF); Dataset: Unambiguous Lipids]

178.53 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

Physikochemische Eigenschaften

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]

P260, P264, P280, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P321, P363, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 92 reports by companies from 1 notifications to the ECHA C&L Inventory.

Gefahrenhinweise

Regulatory Information5,8,11,14,17-Eicosapentaenoic acid, (5Z,8Z,11Z,14Z,17Z)-: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Hazard Classes and CategoriesSkin Corr. 1B (100%)

Sicherheitsdaten

F
8-10-23
wgk
3
ridadr
UN 3265 8/PG 3
hs_code
29161900
risk_code
34
hazard_code
C
safety_code
26-36/37/39-45
hazard_class
8
Speicherklasse
10 - Combustible liquids

Chemie und Industrie

Pharmakologische Informationen

Pharmacodynamics · 1 Eintrag

Eicosanoids are chemical messengers derived from 20-carbon polyunsaturated fatty acids that play critical roles in immune and inflammatory responses. Both 20-carbon omega-6 fatty acids (arachidonic acid) and 20-carbon omega-3 fatty acids (EPA) can be found in cell membranes. During an inflammatory response, arachidonic acid and EPA are metabolized by enzymes known as cyclooxygenases and lipoxygenases to form eicosanoids. Increasing omega-3 fatty acid intake increases the EPA content of cell membranes and decreases the arachidonic acid content, resulting in higher proportions of eicosanoids derived from EPA. Physiologic responses to arachidonic acid-derived eicosanoids differ from responses to EPA-derived eicosanoids. In general, eicosanoids derived from EPA are less potent inducers of inflammation, blood vessel constriction, and clotting than eicosanoids derived from arachidonic acid.

Mechanism of Action · 1 Eintrag

The anti-inflammatory, antithrombotic and immunomodulatory actions of EPA is probably due to its role in eicosanoid physiology and biochemistry. Most eicosanoids are produced by the metabolism of omega-3 fatty acids, specifically, arachidonic acid. These eicosanoids, leukotriene B4 (LTB4) and thromboxane A2 (TXA2) stimulate leukocyte chemotaxis, platelet aggregation and vasoconstriction. They are thrombogenic and artherogenic. On the other hand, EPA is metabolized to leukotriene B5 (LTB5) and thromboxane A3 (TXA3), which are eicosanoids that promote vasodilation, inhibit platelet aggregation and leukocyte chemotaxis and are anti-artherogenic and anti-thrombotic. The triglyceride-lowering effect of EPA results from inhibition of lipogenesis and stimulation of fatty acid oxidation. Fatty acid oxidation of EPA occurs mainly in the mitochondria. EPA is a substrate for Prostaglandin-endoperoxide synthase 1 and 2. It also appears to affect the function and bind to the Carbohydrate responsive element binding protein (ChREBP) and to a fatty acid receptor (G-coupled receptor) known as GP40.

Metabolism/MetabolitesEicosapentaenoic acid has known human metabolites that include Juniperonic acid.
Tissue LocationsAdipose Tissue
Cellular Locations

Zugehörige Reaktionen

32
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 28306
HRID 28306als Eduktuspto-grants-2008_09
Reaktionsgleichung von HRID 339287
HRID 339287als Eduktuspto-grants-2014_11
Reaktionsgleichung von HRID 339293
HRID 339293als Eduktuspto-grants-2014_11
Reaktionsgleichung von HRID 591104
HRID 591104als Eduktuspto-grants-2016_01
Reaktionsgleichung von HRID 591110
HRID 591110als Eduktuspto-grants-2016_01
Reaktionsgleichung von HRID 869791
HRID 869791als Eduktuspto-grants-2015_03
Reaktionsgleichung von HRID 922081
HRID 922081als Eduktuspto-grants-2016_03
Reaktionsgleichung von HRID 922087
HRID 922087als Eduktuspto-grants-2016_03
ZurückSeite 1 von 4

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
DTXSID9041023
ChEMBL
CHEMBL460026
ChEBI
CHEBI:28364
UNII
AAN7QOV9EA
EC Number
600-528-7
Nikkaji
J343.473G
Schmelzpunkt
54 · −54-−53 °C(lit.)
Siedepunkt
439 ℃ · 439℃
Dichte
0.943 g/mL · 0.943 g/mL at 25 °C(lit.)
Brechungsindex
20 · n20/D 1.4977(lit.)
Flammpunkt
93 °C · 93 °C
storage temp.
-20 °C · -20°C
Löslichkeit
Soluble in methanol
Aggregatzustand
liquid
pka
4.75 · 4.75±0.10(Predicted)
Farbe
Colorless to pale yellow
Biologische Quelle
fish oil
Merck
14 · 14,3531
BRN
1714433 · 1714433
Stabilität
1 year · Stable for 1 year as supplied (unopened). After opening, EPA must be stored under inert gas at -80°C. Solutions in DMSO or ethanol should also be stored under inert gas and may be kept at -80°C for up to 2 months.
Kosmetik-Inhaltsstoffe Funktionen
SKIN CONDITIONINGSKIN CONDITIONING - EMOLLIENT
InChIKey
RRGOKSYVAZDNKR-ARJAWSKDSA-N
SMILES
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(O)=O
LogP
6.232 · 6.232 (est)
Extracellular
Metabolite Pathwaysalpha-Linolenic acid metabolism

Verwendung und Herstellung

Use ClassificationCosmetics -> Emollient; Skin conditioning
Anwendungen · 1 Eintrag

Verwendencis-5,8,11,14,17-Eicosapentaenoic acid has been used:to test pharmacologic effect on steatosis in hepatocytesas an analytical standard in Raman spectra measurements to characterize human breast cancer samplesin lipid peroxidation assay in mouse embryonic fibroblasts and in pre-treatment of cells for cell viability studies

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

unsaturated fatty acidFatty acid ethyl esterle, Menhaden-HarnstoffLight alkaline waterIcosa-5,8,11,14-tetraensure

Nachgelagerte Produkte

cis-5,8,11,14,17-Eicosapentaenoic acid methyl ester

Ergänzende Hinweise

DefinitionChEBI: An icosapentaenoic acid having five cis-double bonds at positions 5, 8, 11, 14 and 17.